Pre-mercato: 56.46 0.81 +1.46%

CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Borsa (CRSP) Ultime notizie

CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Borsa (CRSP) Ultime notizie

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well

CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss

CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales

CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?

Wall Street Breakfast: The Week Ahead

CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to Know

3 Biotech Stocks to Buy and Hold Through 2030 and Beyond

Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock

Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?

CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note

Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why

CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2024 Update

Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

bluebird (BLUE) Underperforms Industry YTD Amid Challenges

3 Magnificent Stocks That Could Double or More by 2030

Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex

Charles River (CRL) Forges Collaboration With Ship of Theseus

CRISPR Therapeutics AG (CRSP) Exceeds Market Returns: Some Facts to Consider

Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics

Bull Market and Beyond: 3 Stocks Just Waiting to Soar

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics

CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know

Vertex (VRTX) Moves Kidney Disease Drug to Phase 3 Development

3 Unstoppable Stocks to Buy Hand Over Fist in April

Crispr Therapeutics: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In Plans

bluebird (BLUE) Misses on Q4 Revenues, Provides Portfolio Updates

3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Vertex (VRTX) Continues to Diversify Beyond CF Franchise

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

Vertex (VRTX) Kidney Disease Drug to Enter Clinical Development

CRISPR Therapeutics (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?

CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to Know

bluebird (BLUE) Gets $175 Million Loan From Hercules, Shares Up

Is It Too Late to Buy CRISPR Therapeutics Stock?

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

Cathie Wood's Ark Invest Keeps Dumping Coinbase Shares Amid Bitcoin, Crypto Buzz

Here's Why CRISPR Therapeutics Stock Climbed 34% in February

CRISPR Therapeutics Stock Has 32% Upside, According to 1 Wall Street Analyst

A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

3 Biotech Stocks to Buy and Hold for the Next 10 Years

Simile a CRSP